Relay Therapeutics, Inc. (RLAY) Earnings
Relay Therapeutics, Inc. is expected to report next earnings on November 5, 2026 (in NaN days), with a consensus EPS estimate of $-0.40. RLAY has beaten EPS estimates in 6 of its last 12 reported quarters (average surprise -4.0% over the last four).
Next earnings
Nov 5, 2026in NaN days
EPS est $-0.40 · Revenue est $2M
Track record
Beat EPS in 6 of 12 quarters
Avg surprise -4.0% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 6, 2026 | $-0.39 | $-0.41 | -4.8% | $350000 | -63.5% |
| May 19, 2026 | $-0.35 | $-0.41 | -17.1% | $3M | -46.2% |
| Nov 6, 2025 | $-0.39 | $-0.43 | -10.3% | — | — |
| Aug 7, 2025 | $-0.49 | $-0.41 | +16.3% | $677000 | +4637.6% |
| Feb 26, 2025 | $-0.57 | $-0.45 | +21.1% | — | — |
| May 2, 2024 | $-0.70 | $-0.62 | +11.4% | — | — |
| Feb 22, 2024 | $-0.76 | $-0.67 | +11.8% | — | — |
| Nov 2, 2023 | $-0.83 | $-0.54 | +34.9% | — | — |
| May 4, 2023 | $-0.70 | $-0.78 | -11.4% | $226000 | +18.9% |
| Feb 23, 2023 | $-0.71 | $-0.56 | +21.1% | $253000 | -6.8% |
| Nov 3, 2022 | $-0.71 | $-0.76 | -7.0% | $344000 | -80.9% |
| Aug 4, 2022 | $-0.62 | $-0.71 | -14.5% | $365000 | -82.5% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.